Endocannabinoid-based CLE Therapy Shows Promise in Early Tests
Early studies of an endocannabinoid-based treatment for cutaneous lupus erythematosus (CLE) showed that it eased skin lesions, according to Hoth Therapeutics, which developed the therapy. Endocannabinoids are cannabis-like molecules naturally produced by the human body, with effects…